Global Intravenous (IV) Solutions Market Growth (Status and Outlook) 2022-2028
- LP 4923912
- 85 Pages
- March 2022
- Medical Devices
The United States Intravenous (IV) Solutions market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Intravenous (IV) Solutions market, reaching US$ million by the year 2028. As for the Europe Intravenous (IV) Solutions landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Intravenous (IV) Solutions players cover ICU Medical Inc. (U.S.), B. Braun Melsungen AG (Germany), Fresenius Kabi AG (Germany), and Baxter (U.S.), etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Intravenous (IV) Solutions market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Peripheral Parenteral Nutrition
Total Parenteral Nutrition
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Hospital & Clinics
Ambulatory
Home Care
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
ICU Medical Inc. (U.S.)
B. Braun Melsungen AG (Germany)
Fresenius Kabi AG (Germany)
Baxter (U.S.)
Amanta Healthcare (India)
Terumo Medical Corporation (Tokyo)
Grifols S.A. (Spain)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Intravenous (IV) Solutions Market Size 2017-2028
2.1.2 Intravenous (IV) Solutions Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Intravenous (IV) Solutions Segment by Type
2.2.1 Peripheral Parenteral Nutrition
2.2.2 Total Parenteral Nutrition
2.3 Intravenous (IV) Solutions Market Size by Type
2.3.1 Intravenous (IV) Solutions Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Intravenous (IV) Solutions Market Size Market Share by Type (2017-2022)
2.4 Intravenous (IV) Solutions Segment by Application
2.4.1 Hospital & Clinics
2.4.2 Ambulatory
2.4.3 Home Care
2.5 Intravenous (IV) Solutions Market Size by Application
2.5.1 Intravenous (IV) Solutions Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Intravenous (IV) Solutions Market Size Market Share by Application (2017-2022)
3 Intravenous (IV) Solutions Market Size by Player
3.1 Intravenous (IV) Solutions Market Size Market Share by Players
3.1.1 Global Intravenous (IV) Solutions Revenue by Players (2020-2022)
3.1.2 Global Intravenous (IV) Solutions Revenue Market Share by Players (2020-2022)
3.2 Global Intravenous (IV) Solutions Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Intravenous (IV) Solutions by Regions
4.1 Intravenous (IV) Solutions Market Size by Regions (2017-2022)
4.2 Americas Intravenous (IV) Solutions Market Size Growth (2017-2022)
4.3 APAC Intravenous (IV) Solutions Market Size Growth (2017-2022)
4.4 Europe Intravenous (IV) Solutions Market Size Growth (2017-2022)
4.5 Middle East & Africa Intravenous (IV) Solutions Market Size Growth (2017-2022)
5 Americas
5.1 Americas Intravenous (IV) Solutions Market Size by Country (2017-2022)
5.2 Americas Intravenous (IV) Solutions Market Size by Type (2017-2022)
5.3 Americas Intravenous (IV) Solutions Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Intravenous (IV) Solutions Market Size by Region (2017-2022)
6.2 APAC Intravenous (IV) Solutions Market Size by Type (2017-2022)
6.3 APAC Intravenous (IV) Solutions Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Intravenous (IV) Solutions by Country (2017-2022)
7.2 Europe Intravenous (IV) Solutions Market Size by Type (2017-2022)
7.3 Europe Intravenous (IV) Solutions Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Intravenous (IV) Solutions by Region (2017-2022)
8.2 Middle East & Africa Intravenous (IV) Solutions Market Size by Type (2017-2022)
8.3 Middle East & Africa Intravenous (IV) Solutions Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Intravenous (IV) Solutions Market Forecast
10.1 Global Intravenous (IV) Solutions Forecast by Regions (2023-2028)
10.1.1 Global Intravenous (IV) Solutions Forecast by Regions (2023-2028)
10.1.2 Americas Intravenous (IV) Solutions Forecast
10.1.3 APAC Intravenous (IV) Solutions Forecast
10.1.4 Europe Intravenous (IV) Solutions Forecast
10.1.5 Middle East & Africa Intravenous (IV) Solutions Forecast
10.2 Americas Intravenous (IV) Solutions Forecast by Country (2023-2028)
10.2.1 United States Intravenous (IV) Solutions Market Forecast
10.2.2 Canada Intravenous (IV) Solutions Market Forecast
10.2.3 Mexico Intravenous (IV) Solutions Market Forecast
10.2.4 Brazil Intravenous (IV) Solutions Market Forecast
10.3 APAC Intravenous (IV) Solutions Forecast by Region (2023-2028)
10.3.1 China Intravenous (IV) Solutions Market Forecast
10.3.2 Japan Intravenous (IV) Solutions Market Forecast
10.3.3 Korea Intravenous (IV) Solutions Market Forecast
10.3.4 Southeast Asia Intravenous (IV) Solutions Market Forecast
10.3.5 India Intravenous (IV) Solutions Market Forecast
10.3.6 Australia Intravenous (IV) Solutions Market Forecast
10.4 Europe Intravenous (IV) Solutions Forecast by Country (2023-2028)
10.4.1 Germany Intravenous (IV) Solutions Market Forecast
10.4.2 France Intravenous (IV) Solutions Market Forecast
10.4.3 UK Intravenous (IV) Solutions Market Forecast
10.4.4 Italy Intravenous (IV) Solutions Market Forecast
10.4.5 Russia Intravenous (IV) Solutions Market Forecast
10.5 Middle East & Africa Intravenous (IV) Solutions Forecast by Region (2023-2028)
10.5.1 Egypt Intravenous (IV) Solutions Market Forecast
10.5.2 South Africa Intravenous (IV) Solutions Market Forecast
10.5.3 Israel Intravenous (IV) Solutions Market Forecast
10.5.4 Turkey Intravenous (IV) Solutions Market Forecast
10.5.5 GCC Countries Intravenous (IV) Solutions Market Forecast
10.6 Global Intravenous (IV) Solutions Forecast by Type (2023-2028)
10.7 Global Intravenous (IV) Solutions Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 ICU Medical Inc. (U.S.)
11.1.1 ICU Medical Inc. (U.S.) Company Information
11.1.2 ICU Medical Inc. (U.S.) Intravenous (IV) Solutions Product Offered
11.1.3 ICU Medical Inc. (U.S.) Intravenous (IV) Solutions Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 ICU Medical Inc. (U.S.) Main Business Overview
11.1.5 ICU Medical Inc. (U.S.) Latest Developments
11.2 B. Braun Melsungen AG (Germany)
11.2.1 B. Braun Melsungen AG (Germany) Company Information
11.2.2 B. Braun Melsungen AG (Germany) Intravenous (IV) Solutions Product Offered
11.2.3 B. Braun Melsungen AG (Germany) Intravenous (IV) Solutions Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 B. Braun Melsungen AG (Germany) Main Business Overview
11.2.5 B. Braun Melsungen AG (Germany) Latest Developments
11.3 Fresenius Kabi AG (Germany)
11.3.1 Fresenius Kabi AG (Germany) Company Information
11.3.2 Fresenius Kabi AG (Germany) Intravenous (IV) Solutions Product Offered
11.3.3 Fresenius Kabi AG (Germany) Intravenous (IV) Solutions Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Fresenius Kabi AG (Germany) Main Business Overview
11.3.5 Fresenius Kabi AG (Germany) Latest Developments
11.4 Baxter (U.S.)
11.4.1 Baxter (U.S.) Company Information
11.4.2 Baxter (U.S.) Intravenous (IV) Solutions Product Offered
11.4.3 Baxter (U.S.) Intravenous (IV) Solutions Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Baxter (U.S.) Main Business Overview
11.4.5 Baxter (U.S.) Latest Developments
11.5 Amanta Healthcare (India)
11.5.1 Amanta Healthcare (India) Company Information
11.5.2 Amanta Healthcare (India) Intravenous (IV) Solutions Product Offered
11.5.3 Amanta Healthcare (India) Intravenous (IV) Solutions Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Amanta Healthcare (India) Main Business Overview
11.5.5 Amanta Healthcare (India) Latest Developments
11.6 Terumo Medical Corporation (Tokyo)
11.6.1 Terumo Medical Corporation (Tokyo) Company Information
11.6.2 Terumo Medical Corporation (Tokyo) Intravenous (IV) Solutions Product Offered
11.6.3 Terumo Medical Corporation (Tokyo) Intravenous (IV) Solutions Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Terumo Medical Corporation (Tokyo) Main Business Overview
11.6.5 Terumo Medical Corporation (Tokyo) Latest Developments
11.7 Grifols S.A. (Spain)
11.7.1 Grifols S.A. (Spain) Company Information
11.7.2 Grifols S.A. (Spain) Intravenous (IV) Solutions Product Offered
11.7.3 Grifols S.A. (Spain) Intravenous (IV) Solutions Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Grifols S.A. (Spain) Main Business Overview
11.7.5 Grifols S.A. (Spain) Latest Developments
12 Research Findings and Conclusion
Table 1. Intravenous (IV) Solutions Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Peripheral Parenteral Nutrition
Table 3. Major Players of Total Parenteral Nutrition
Table 4. Intravenous (IV) Solutions Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 5. Global Intravenous (IV) Solutions Market Size by Type (2017-2022) & ($ Millions)
Table 6. Global Intravenous (IV) Solutions Market Size Market Share by Type (2017-2022)
Table 7. Intravenous (IV) Solutions Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global Intravenous (IV) Solutions Market Size by Application (2017-2022) & ($ Millions)
Table 9. Global Intravenous (IV) Solutions Market Size Market Share by Application (2017-2022)
Table 10. Global Intravenous (IV) Solutions Revenue by Players (2020-2022) & ($ Millions)
Table 11. Global Intravenous (IV) Solutions Revenue Market Share by Player (2020-2022)
Table 12. Intravenous (IV) Solutions Key Players Head office and Products Offered
Table 13. Intravenous (IV) Solutions Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Intravenous (IV) Solutions Market Size by Regions 2017-2022 & ($ Millions)
Table 17. Global Intravenous (IV) Solutions Market Size Market Share by Regions (2017-2022)
Table 18. Americas Intravenous (IV) Solutions Market Size by Country (2017-2022) & ($ Millions)
Table 19. Americas Intravenous (IV) Solutions Market Size Market Share by Country (2017-2022)
Table 20. Americas Intravenous (IV) Solutions Market Size by Type (2017-2022) & ($ Millions)
Table 21. Americas Intravenous (IV) Solutions Market Size Market Share by Type (2017-2022)
Table 22. Americas Intravenous (IV) Solutions Market Size by Application (2017-2022) & ($ Millions)
Table 23. Americas Intravenous (IV) Solutions Market Size Market Share by Application (2017-2022)
Table 24. APAC Intravenous (IV) Solutions Market Size by Region (2017-2022) & ($ Millions)
Table 25. APAC Intravenous (IV) Solutions Market Size Market Share by Region (2017-2022)
Table 26. APAC Intravenous (IV) Solutions Market Size by Type (2017-2022) & ($ Millions)
Table 27. APAC Intravenous (IV) Solutions Market Size Market Share by Type (2017-2022)
Table 28. APAC Intravenous (IV) Solutions Market Size by Application (2017-2022) & ($ Millions)
Table 29. APAC Intravenous (IV) Solutions Market Size Market Share by Application (2017-2022)
Table 30. Europe Intravenous (IV) Solutions Market Size by Country (2017-2022) & ($ Millions)
Table 31. Europe Intravenous (IV) Solutions Market Size Market Share by Country (2017-2022)
Table 32. Europe Intravenous (IV) Solutions Market Size by Type (2017-2022) & ($ Millions)
Table 33. Europe Intravenous (IV) Solutions Market Size Market Share by Type (2017-2022)
Table 34. Europe Intravenous (IV) Solutions Market Size by Application (2017-2022) & ($ Millions)
Table 35. Europe Intravenous (IV) Solutions Market Size Market Share by Application (2017-2022)
Table 36. Middle East & Africa Intravenous (IV) Solutions Market Size by Region (2017-2022) & ($ Millions)
Table 37. Middle East & Africa Intravenous (IV) Solutions Market Size Market Share by Region (2017-2022)
Table 38. Middle East & Africa Intravenous (IV) Solutions Market Size by Type (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Intravenous (IV) Solutions Market Size Market Share by Type (2017-2022)
Table 40. Middle East & Africa Intravenous (IV) Solutions Market Size by Application (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Intravenous (IV) Solutions Market Size Market Share by Application (2017-2022)
Table 42. Key Market Drivers & Growth Opportunities of Intravenous (IV) Solutions
Table 43. Key Market Challenges & Risks of Intravenous (IV) Solutions
Table 44. Key Industry Trends of Intravenous (IV) Solutions
Table 45. Global Intravenous (IV) Solutions Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 46. Global Intravenous (IV) Solutions Market Size Market Share Forecast by Regions (2023-2028)
Table 47. Global Intravenous (IV) Solutions Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 48. Global Intravenous (IV) Solutions Market Size Market Share Forecast by Type (2023-2028)
Table 49. Global Intravenous (IV) Solutions Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 50. Global Intravenous (IV) Solutions Market Size Market Share Forecast by Application (2023-2028)
Table 51. ICU Medical Inc. (U.S.) Details, Company Type, Intravenous (IV) Solutions Area Served and Its Competitors
Table 52. ICU Medical Inc. (U.S.) Intravenous (IV) Solutions Product Offered
Table 53. ICU Medical Inc. (U.S.) Intravenous (IV) Solutions Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 54. ICU Medical Inc. (U.S.) Main Business
Table 55. ICU Medical Inc. (U.S.) Latest Developments
Table 56. B. Braun Melsungen AG (Germany) Details, Company Type, Intravenous (IV) Solutions Area Served and Its Competitors
Table 57. B. Braun Melsungen AG (Germany) Intravenous (IV) Solutions Product Offered
Table 58. B. Braun Melsungen AG (Germany) Main Business
Table 59. B. Braun Melsungen AG (Germany) Intravenous (IV) Solutions Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 60. B. Braun Melsungen AG (Germany) Latest Developments
Table 61. Fresenius Kabi AG (Germany) Details, Company Type, Intravenous (IV) Solutions Area Served and Its Competitors
Table 62. Fresenius Kabi AG (Germany) Intravenous (IV) Solutions Product Offered
Table 63. Fresenius Kabi AG (Germany) Main Business
Table 64. Fresenius Kabi AG (Germany) Intravenous (IV) Solutions Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 65. Fresenius Kabi AG (Germany) Latest Developments
Table 66. Baxter (U.S.) Details, Company Type, Intravenous (IV) Solutions Area Served and Its Competitors
Table 67. Baxter (U.S.) Intravenous (IV) Solutions Product Offered
Table 68. Baxter (U.S.) Main Business
Table 69. Baxter (U.S.) Intravenous (IV) Solutions Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 70. Baxter (U.S.) Latest Developments
Table 71. Amanta Healthcare (India) Details, Company Type, Intravenous (IV) Solutions Area Served and Its Competitors
Table 72. Amanta Healthcare (India) Intravenous (IV) Solutions Product Offered
Table 73. Amanta Healthcare (India) Main Business
Table 74. Amanta Healthcare (India) Intravenous (IV) Solutions Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 75. Amanta Healthcare (India) Latest Developments
Table 76. Terumo Medical Corporation (Tokyo) Details, Company Type, Intravenous (IV) Solutions Area Served and Its Competitors
Table 77. Terumo Medical Corporation (Tokyo) Intravenous (IV) Solutions Product Offered
Table 78. Terumo Medical Corporation (Tokyo) Main Business
Table 79. Terumo Medical Corporation (Tokyo) Intravenous (IV) Solutions Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 80. Terumo Medical Corporation (Tokyo) Latest Developments
Table 81. Grifols S.A. (Spain) Details, Company Type, Intravenous (IV) Solutions Area Served and Its Competitors
Table 82. Grifols S.A. (Spain) Intravenous (IV) Solutions Product Offered
Table 83. Grifols S.A. (Spain) Main Business
Table 84. Grifols S.A. (Spain) Intravenous (IV) Solutions Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 85. Grifols S.A. (Spain) Latest Developments
List of Figures
Figure 1. Intravenous (IV) Solutions Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Intravenous (IV) Solutions Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Intravenous (IV) Solutions Market Size Market Share by Type in 2021
Figure 7. Intravenous (IV) Solutions in Hospital & Clinics
Figure 8. Global Intravenous (IV) Solutions Market: Hospital & Clinics (2017-2022) & ($ Millions)
Figure 9. Intravenous (IV) Solutions in Ambulatory
Figure 10. Global Intravenous (IV) Solutions Market: Ambulatory (2017-2022) & ($ Millions)
Figure 11. Intravenous (IV) Solutions in Home Care
Figure 12. Global Intravenous (IV) Solutions Market: Home Care (2017-2022) & ($ Millions)
Figure 13. Global Intravenous (IV) Solutions Market Size Market Share by Application in 2021
Figure 14. Global Intravenous (IV) Solutions Revenue Market Share by Player in 2021
Figure 15. Global Intravenous (IV) Solutions Market Size Market Share by Regions (2017-2022)
Figure 16. Americas Intravenous (IV) Solutions Market Size 2017-2022 ($ Millions)
Figure 17. APAC Intravenous (IV) Solutions Market Size 2017-2022 ($ Millions)
Figure 18. Europe Intravenous (IV) Solutions Market Size 2017-2022 ($ Millions)
Figure 19. Middle East & Africa Intravenous (IV) Solutions Market Size 2017-2022 ($ Millions)
Figure 20. Americas Intravenous (IV) Solutions Value Market Share by Country in 2021
Figure 21. Americas Intravenous (IV) Solutions Consumption Market Share by Type in 2021
Figure 22. Americas Intravenous (IV) Solutions Market Size Market Share by Application in 2021
Figure 23. United States Intravenous (IV) Solutions Market Size Growth 2017-2022 ($ Millions)
Figure 24. Canada Intravenous (IV) Solutions Market Size Growth 2017-2022 ($ Millions)
Figure 25. Mexico Intravenous (IV) Solutions Market Size Growth 2017-2022 ($ Millions)
Figure 26. Brazil Intravenous (IV) Solutions Market Size Growth 2017-2022 ($ Millions)
Figure 27. APAC Intravenous (IV) Solutions Market Size Market Share by Region in 2021
Figure 28. APAC Intravenous (IV) Solutions Market Size Market Share by Application in 2021
Figure 29. China Intravenous (IV) Solutions Market Size Growth 2017-2022 ($ Millions)
Figure 30. Japan Intravenous (IV) Solutions Market Size Growth 2017-2022 ($ Millions)
Figure 31. Korea Intravenous (IV) Solutions Market Size Growth 2017-2022 ($ Millions)
Figure 32. Southeast Asia Intravenous (IV) Solutions Market Size Growth 2017-2022 ($ Millions)
Figure 33. India Intravenous (IV) Solutions Market Size Growth 2017-2022 ($ Millions)
Figure 34. Australia Intravenous (IV) Solutions Market Size Growth 2017-2022 ($ Millions)
Figure 35. Europe Intravenous (IV) Solutions Market Size Market Share by Country in 2021
Figure 36. Europe Intravenous (IV) Solutions Market Size Market Share by Type in 2021
Figure 37. Europe Intravenous (IV) Solutions Market Size Market Share by Application in 2021
Figure 38. Germany Intravenous (IV) Solutions Market Size Growth 2017-2022 ($ Millions)
Figure 39. France Intravenous (IV) Solutions Market Size Growth 2017-2022 ($ Millions)
Figure 40. UK Intravenous (IV) Solutions Market Size Growth 2017-2022 ($ Millions)
Figure 41. Italy Intravenous (IV) Solutions Market Size Growth 2017-2022 ($ Millions)
Figure 42. Russia Intravenous (IV) Solutions Market Size Growth 2017-2022 ($ Millions)
Figure 43. Middle East & Africa Intravenous (IV) Solutions Market Size Market Share by Region in 2021
Figure 44. Middle East & Africa Intravenous (IV) Solutions Market Size Market Share by Type in 2021
Figure 45. Middle East & Africa Intravenous (IV) Solutions Market Size Market Share by Application in 2021
Figure 46. Egypt Intravenous (IV) Solutions Market Size Growth 2017-2022 ($ Millions)
Figure 47. South Africa Intravenous (IV) Solutions Market Size Growth 2017-2022 ($ Millions)
Figure 48. Israel Intravenous (IV) Solutions Market Size Growth 2017-2022 ($ Millions)
Figure 49. Turkey Intravenous (IV) Solutions Market Size Growth 2017-2022 ($ Millions)
Figure 50. GCC Country Intravenous (IV) Solutions Market Size Growth 2017-2022 ($ Millions)
Figure 51. Americas Intravenous (IV) Solutions Market Size 2023-2028 ($ Millions)
Figure 52. APAC Intravenous (IV) Solutions Market Size 2023-2028 ($ Millions)
Figure 53. Europe Intravenous (IV) Solutions Market Size 2023-2028 ($ Millions)
Figure 54. Middle East & Africa Intravenous (IV) Solutions Market Size 2023-2028 ($ Millions)
Figure 55. United States Intravenous (IV) Solutions Market Size 2023-2028 ($ Millions)
Figure 56. Canada Intravenous (IV) Solutions Market Size 2023-2028 ($ Millions)
Figure 57. Mexico Intravenous (IV) Solutions Market Size 2023-2028 ($ Millions)
Figure 58. Brazil Intravenous (IV) Solutions Market Size 2023-2028 ($ Millions)
Figure 59. China Intravenous (IV) Solutions Market Size 2023-2028 ($ Millions)
Figure 60. Japan Intravenous (IV) Solutions Market Size 2023-2028 ($ Millions)
Figure 61. Korea Intravenous (IV) Solutions Market Size 2023-2028 ($ Millions)
Figure 62. Southeast Asia Intravenous (IV) Solutions Market Size 2023-2028 ($ Millions)
Figure 63. India Intravenous (IV) Solutions Market Size 2023-2028 ($ Millions)
Figure 64. Australia Intravenous (IV) Solutions Market Size 2023-2028 ($ Millions)
Figure 65. Germany Intravenous (IV) Solutions Market Size 2023-2028 ($ Millions)
Figure 66. France Intravenous (IV) Solutions Market Size 2023-2028 ($ Millions)
Figure 67. UK Intravenous (IV) Solutions Market Size 2023-2028 ($ Millions)
Figure 68. Italy Intravenous (IV) Solutions Market Size 2023-2028 ($ Millions)
Figure 69. Russia Intravenous (IV) Solutions Market Size 2023-2028 ($ Millions)
Figure 70. Spain Intravenous (IV) Solutions Market Size 2023-2028 ($ Millions)
Figure 71. Egypt Intravenous (IV) Solutions Market Size 2023-2028 ($ Millions)
Figure 72. South Africa Intravenous (IV) Solutions Market Size 2023-2028 ($ Millions)
Figure 73. Israel Intravenous (IV) Solutions Market Size 2023-2028 ($ Millions)
Figure 74. Turkey Intravenous (IV) Solutions Market Size 2023-2028 ($ Millions)
Figure 75. GCC Countries Intravenous (IV) Solutions Market Size 2023-2028 ($ Millions)
Similar Reports
This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
